Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Outgoing CEO Jimmy Vanhove will head expansion of Bayer’s U.S. pharma product supply network, while Angela Ochoa Chico comes over from Bayer.
October 19, 2026
By: Patrick Lavery
Why This Matters: See our coverage of other industry executive team appointments and promotions here.
Viralgen, a CDMO specializing in adeno-associated virus (AAV) gene therapy manufacturing, announced a planned Chief Executive Officer (CEO) succession.
Outgoing CEO Jimmy Vanhove will transition to leading development and expansion of Bayer’s United States Pharmaceutical Product Supply Network. Vanhove will be based in New Albany, Ohio, but remains connected in a way to Viralgen. Located in San Sebastian, Spain, Viralgen is a subsidiary of AskBio, which is within the Bayer Group.
In his new role, Vanhove will join Bayer’s Pharmaceutical Division Product Supply Leadership Team. This is the division which Vanhove’s successor, Angela Ochoa Chico, is now leaving for Viralgen. Ochoa Chico had been Product Supply Strategy & Excellence Lead there.
The succession takes effect Jan. 1, 2027.
“It has been a privilege to lead Viralgen through this transformative period,” Vanhove said. “[We’re] committed to people living with both common and rare diseases, as well as the patient foundations that represent them. I am confident that Angela will build on this legacy and lead Viralgen into its next exciting chapter.”
“I am delighted to join Viralgen at such an important stage in its evolution,” Ochoa Chico said. “Viralgen has built an outstanding reputation for scientific excellence, quality, and innovation, supported by an exceptionally talented team. I look forward to building on these strong foundations, advancing our manufacturing capabilities, and further strengthening Viralgen’s position.”
At its headquarters in Spain, Viralgen employs more than 450 professionals. In addition, the company operates one of the world’s largest facilities devoted to AAV-based gene therapy manufacturing.
Viralgen’s integrated capabilities include process development, clinical and commercial production, quality control, and fill-finish.
Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
